Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU5F-2P (RNA, U5F small nuclear 2, pseudogene) is classified as a **pseudogene** member of the U5 small nuclear RNA (snRNA) family[1]. Functional U5 snRNAs are basic components of the **major spliceosome**, which is responsible for pre-mRNA splicing in eukaryotes, but **RNU5F-2P does not encode a functional RNA or protein product and is not known to participate in biological processes or disease mechanisms**[1]. Functional relevance and disease association have been noted for other U5 snRNA genes (such as RNU5A-1 and RNU5B-1), but not for RNU5F-2P[3][4]. There is no therapeutic or diagnostic utility attributed to RNU5F-2P[1].
Not applicable (no known pharmacological interactions)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U5F small nuclear 2, pseudogene (RNU5F-2P).